Niagen Bioscience宣布将旗下Chromadex参考标准业务以全现金交易方式出售给LGC,旨在优化公司架构并集中资源发展核心业务。此次交易将帮助Niagen Bioscience进一步聚焦主营业务,提升运营效率。
Niagen Bioscience宣布将旗下Chromadex参考标准业务以全现金交易方式出售给LGC,旨在优化公司架构并集中资源发展核心业务。此次交易将帮助Niagen Bioscience进一步聚焦主营业务,提升运营效率。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.